[Expert consensus post-marketing evaluation scheme to detect immunotoxicity of Chinese medicine in clinical populations (draft version for comments)]

Zhongguo Zhong Yao Za Zhi. 2013 Sep;38(18):2933-6.
[Article in Chinese]

Abstract

Through consensus, establish a post-marketing scheme and the technical processes to evaluate Chinese medicine's immunotoxicity on a population, as well as its beneficial influences on the immune system. Provide regulations on the collection, storage and transportation of serum samples. This article applies to the post-marketing scientific evaluation of the immunotoxicity of parenterally administered, and for other ways of taking Chinese medicine.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Consensus
  • Drug Hypersensitivity / etiology
  • Drug Hypersensitivity / immunology*
  • Drug Monitoring / adverse effects
  • Drug Monitoring / methods*
  • Drug Monitoring / standards
  • Drugs, Chinese Herbal / adverse effects*
  • Expert Testimony
  • Humans
  • Immunologic Techniques / methods*
  • Immunologic Techniques / standards
  • Product Surveillance, Postmarketing / methods*
  • Product Surveillance, Postmarketing / standards
  • Th1 Cells / immunology
  • Th2 Cells / immunology

Substances

  • Drugs, Chinese Herbal